Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
XGN
$7.03
+0.86%
XGN
· Exagen Inc.
Market Cap
$170.30M
Shares
24.23M
All earnings calls
Earnings call · FY2026 Q2
Exagen Inc. (XGN) Q2 2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$19.94M
+15.9% YoY
Diluted EPS
-$0.13
Gross margin
61.3%
+0.9 pp YoY
Net income
-$3.20M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 4, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Full-year 2026 revenue
Initiated
full-year 2026
|
$72M – $75M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 4, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 4, 2026 · complete as-filed document